logo_new_en

UL FFA - ARRS logo





Research programmes

Show for type:

All types
1.03 Natural sciences and mathematics / Biology
1.04 Natural Sciences and mathematics/Chemistry
1.04.02 Natural sciences and mathematics / Chemistry / Structural chemistry
1.05 Natural sciences and mathematics/Biochemistry and molecular biology
1.07. Natural sciences and mathematics / Computer intensive methods and applications
1.09 Pharmacy
1-09 Natural sciences and Mathematics - Pharmacy
2.04 Ingeeniring Sciences Technologies / Material Science and Technology
2.05.02 Engineering sciences and technologies/Mechanics/Experimental mechanics
2.06 Engineering sciences and technologies / Systems and cybernetics
2.13 Engineering sciences and technologies / Process engineering
3.00 Medical Sciences
3.01 Medical sciences/ Microbiology and immunology
3.03 Medical sciences/ Neurobiology
3.04 Medical Sciences/Oncology
3.05 Medical sciences / Human reproduction
3.06 Medical sciences / Cardiovascular system
3.07 Medical sciences/Metabolic and hormonal disorders
3.08 Medical Sciences / Public Health
4.00 Biotechnical Sciences
4.01.02 Biotechnical sciences / Forestry, wood and paper technology / Wood technology
4.03 Biotechnical sciences / Plant production
4.04.03 Biotechnical sciences / Veterinarian medicine / Therapy and health prevention of animals
4.06 Biotehniške vede
4.06 Biotechnical sciences / Biotechnology
4.06.01 Biotechnical sciences-Biotechnology-Recombinant DNA technology
4.06.02 Biotechnical sciences / Biotechnology / Bio-engineering
4.06.04 Biotechnical sciences/Biotechnology/Microbe biotechnology

Range:

Advanced immunological drugs and cell-based approaches in pharmacy

The development of safe and effective vaccines against infectious diseases such as SARS-CoV2, Zika, malaria, Ebola and the emerging zoonoses is a major goal in global public health. Also, cancer clearly remains one of the leading causes of disease and mortality worldwide. Recent advances in immunotherapy and cell therapy established them as potential new modalities ...

01. January 2022 - 31. December 2027 | 1-09 Natural sciences and Mathematics - Pharmacy, 3.01 Medical sciences/ Microbiology and immunology

Genes, hormones and personality changes in metabolic disorders

In the last two decades our programme P3-0298 is based on activities and achievements in basic, laboratory and clinical research in the field of chronic metabolic disorders such as osteoporosis and bone metabolism, polycystic ovary syndrome (PCOS), diabetes type 2 and insulin resistance as a common component of the last two disorders. During 20 years we published mo...

01. January 2019 - 31. December 2024 | 3.07 Medical sciences/Metabolic and hormonal disorders, 1-09 Natural sciences and Mathematics - Pharmacy

Pharmaceutical technology: from drug delivery systems to therapeutic outcomes of medicines in children end elderly

The main focus of the Programme Group “Pharmaceutical technology: from drug delivery systems to therapeutic outcomes of medicines in children and elderly” is the delivery of the active pharmaceutical ingredients (API) to the targeted site in the body and the optimization of drug therapy in different groups of patients. The Group's research programme is d...

01. January 2018 - 31. December 2024 | 3.07 Medical sciences/Metabolic and hormonal disorders, 1-09 Natural sciences and Mathematics - Pharmacy

Pharmaceutical biotechnology: Science for health

Cancer, neurodegenerative and immune diseases represent a great health and social burden for our society. Due to prolongation of life expectancy the burden of these predominantly  age-related diseases is anticipated to be even greater in the future. To avoid the collapse of the health care system, new, more effective therapy strategies are urgently needed. Our ...

01. January 2019 - 31. December 2024 | 4.06.01 Biotechnical sciences-Biotechnology-Recombinant DNA technology, 1-09 Natural sciences and Mathematics - Pharmacy

Systemic Autoimmune diseases

Our research program P3-0314 encompasses rheumatologists, pulmonologists, neurologists, gastroenterologists, biochemists, pharmacists, molecular/cell biologists, biostaticians/bioinformaticians, laboratory experts, economists and patients groups. Activities are predominantly geared towards optimization of therapy/drug repurposing, elucidation of disease mechanism fo...

01. January 2022 - 31. December 2027 | 3.01 Medical sciences/ Microbiology and immunology

Advanced immunological drugs and cell-based approaches in pharmacy

The development of safe and effective vaccines against infectious diseases such as SARS-CoV2, Zika, malaria, Ebola and the emerging zoonoses is a major goal in global public health. Also, cancer clearly remains one of the leading causes of disease and mortality worldwide. Recent advances in immunotherapy and cell therapy established them as potential new modalities ...

01. January 2022 - 31. December 2027 | 1.09 Pharmacy, 3.01 Medical sciences/ Microbiology and immunology

Medicinal chemistry - drug design, synthesis and evaluation

The long-term goal of the research programme is the discovery of new bioactive small molecules with a potential for development into drugs for use in important therapeutic areas through combined medicinal chemistry approaches. In the next period, the research programme will focus on the discovery and rational design, synthesis and biological evaluation of molecules ...

01. January 2022 - 31. December 2027 | 1-09 Natural sciences and Mathematics - Pharmacy

Pharmaceutical biotechnology: Science for health

Cancer, neurodegenerative and immune diseases represent a great health and social burden for our society. Due to prolongation of life expectancy the burden of these predominantly  age-related diseases is anticipated to be even greater in the future. To avoid the collapse of the health care system, new, more effective therapy strategies are urgently needed. Our ...

01. January 2015 - 31. December 2018 | 4.00 Biotechnical Sciences

Genes, hormones and personality changes in metabolic disorders

Our programme is based on activities and achievements in the last two decades in the field of chronic metabolic disorders such as osteoporosis and bone metabolism, polycystic ovary syndrome (PCOS), diabetes type 2 (and to a lesser degree type 1) and insulin resistance as a common component of the last two disorders. The majority of our activities will be further res...

01. January 2015 - 31. December 2018 | 3.00 Medical Sciences

Medicinal chemistry - drug design, synthesis and evaluation

 The long-term goal of the research programme is discovery of new bioactive small molecules with a potential for development to drugs in important therapeutic areas through combined medicinal chemistry approaches. In the next period the research programme will focus on discovery and rational design of bioactive molecules exerting their action on validated drug ...

01. January 2015 - 31. December 2021 | 1.09 Pharmacy, 1.04 Natural Sciences and mathematics/Chemistry